|
 |
AldurazymeThis page contains recent news articles, when available, and an overview of Aldurazyme but does not offer medical advice. You should contact your physician with regard to any health issues or concerns.The agency recommended that doctors closely inspect vials of Cerezyme, Fabrazyme, Myozyme, Aldurazyme and Thyrogen. Cerezyme treats a rare enzyme disorder ... ABC News Peninsula News - Dec 10, 2009 Her two grown children have benefitted from Aldurazyme, a breakthrough drug treatment that Kakkis and a team of scientists first developed at LA BioMed. ... Palos Verdes Peninsula News Some genetic drugs impure - 14 Nov 2009 Medicines affected include Cerezyme, Genzyme's biggest selling product, as well as Fabrazyme, Myozyme, Aldurazyme and Thyrogen. The contaminated drugs were ... Chicago Tribune National business briefs - 14 Nov 2009 The drugs, which are used to treat rare enzyme disorders, include: Cerezyme, Fabrazyme, Myozyme, Aldurazyme and Thyrogen. ... NewsOK.com Drug company warns of contamination - 14 Nov 2009 The contaminated products are marketed by Genzyme under the names Cerezyme, Fabrayzme, Myozyme, Aldurazyme and Thyrogen. Stockhouse Genzyme Issues Letters to US Healthcare Providers - 14 Nov 2009 Fabrazyme ® (agalsidase beta), Myozyme ® (alglucosidase alfa), Aldurazyme ® (laronidase), as well as Thyrogen ® (thyrotropin alfa for injection), ... Genetic Engineering News (press release) US stocks advance - 14 Nov 2009 US regulators said some lots of the company's Cerezyme, Fabrazyme, Myozyme, Aldurazyme, and Thyrogen may be contaminated with stainless steel fragments, ... The Age Foreign Particles Found In Some Genzyme Medicines - 14 Nov 2009 ...adverse effects associated with the products, which include Genzyme's top sellers Cerezyme and Fabrazyme, as well as Myozyme, Aldurazyme and Thyrogen. ... Easy Bourse חדשות טובות עבור פרוטליקס? חשש ×›×™ תרופות של חברת ×’'× ×–×™×™×? זוהמו במתכת וגומי - 14 Nov 2009 ...התרופות, בהן כמה ×ž×”× ×ž×›×¨×•×ª ביותר של החברה, שקיי×? חשש לזיהו×? בחלקן הן: Cerezyme, Fabrazyme, Myozyme, Aldurazyme ו-Thyrogen. "זיהומי×? ×?לה עלולי×? לגרו×? ל×?ירועי×? ... The Marker וול סטריט בדרך לשבוע ×©× ×™ של עליות: × ×?סד"ק עולה ב-1%; דולר ×’'× ×¨×œ עולה ב-8% ביו×? ... - 14 Nov 2009 ...התרופות, בהן כמה מהתרופות ×”× ×ž×›×¨×•×ª ביותר של החברה, שהופצו ו×?שר קיי×? חשש לזיהו×? בחלקן הן: Cerezyme, Fabrazyme, Myozyme, Aldurazyme ו-Thyrogen. ... The Marker Particles Detected in Vials from Genzyme's Plant Not Expected to Impact ... - Nov 13, 2009 For Aldurazyme, this is essentially a reminder as the Aldurazyme approved product label has always recommended the use of a 0.22 micron filter when ... PR Newswire (press release) UPDATE 1-U.S. FDA: Some Genzyme drugs contaminated - Nov 13, 2009 The FDA said the affected products included Cerezyme for Gaucher disease, Fabrazyme for Fabry disease, Myozyme for Pompe disease, Aldurazyme for ... 路透中国 Former LA BioMed investigator Emil D. Kakkis, MD, PhD, and county supervisor ... - Nov 12, 2009 He also was introduced by Tami Slawson, the mother of two grown children who have benefitted from Aldurazyme®, the breakthrough treatment Dr. Kakkis and a ... EurekAlert (press release) BioMarin Announces Third Quarter 2009 Financial Results - Oct 28, 2009 Net sales of Aldurazyme (laronidase), an enzyme replacement therapy for mucopolysaccharidosis I (MPS I) recorded by Genzyme, were $40.3 million for the ... Reuters BioMarin to Present at the Credit Suisse Healthcare Conference - Nov 4, 2009 BioMarin®, Naglazyme® and Kuvan® are registered trademarks of BioMarin Pharmaceutical Inc. Aldurazyme® is a registered trademark of BioMarin/Genzyme LLC. ... Reuters BioMarin to Present at the Oppenheimer Healthcare Conference - Oct 27, 2009 BioMarin®, Naglazyme® and Kuvan® are registered trademarks of BioMarin Pharmaceutical Inc. Aldurazyme® is a registered trademark of BioMarin/Genzyme LLC. ... Reuters United States Patent Office Issues Patent Covering the Approved Administration ... - Nov 5, 2009 BioMarin®, Naglazyme® and Kuvan® are registered trademarks of BioMarin Pharmaceutical Inc. Aldurazyme® is a registered trademark of BioMarin/Genzyme LLC. ... Reuters FDA Said Pieces Of Steel, Rubber, Fiber Found In Drugs Made By Genzyme (GENZ) - Nov 13, 2009 The drugs include Cerezyme, Fabrazyme, Myozyme, Aldurazyme, and Thyrogen. The FDA estimated that contamination only affected about 1% of the company's ... Trading Markets (press release) FDA finds bits of steel, rubber in Genzyme drugs - Nov 13, 2009 The drugs, which are used to treat rare enzyme disorders, include: Cerezyme, Fabrazyme, Myozyme, Aldurazyme and Thyrogen. ... phillyBurbs.com FDA finds bits of steel, rubber in Genzyme drugs - Nov 13, 2009 The drugs affected by the latest announcement include: Cerezyme, Fabrazyme, Myozyme, Aldurazyme and Thyrogen. All are manufactured at a biotech plant in ... Kansas City Star BioMarin Pharmaceutical to Present at Credit Suisse Healthcare Conference - Nov 4, 2009 ...a product wholly developed and commercialized by BioMarin; Aldurazyme® (laronidase) for mucopolysaccharidosis I (MPS I), a product which BioMarin ... TransWorldNews (press release) Genzyme Q3 Profit Falls 87%; Cuts FY09 Earnings Outlook - Oct 21, 2009 Sales for Hurler syndrome treatment drug Aldurazyme increased marginally to $40.3 million from $38.2 million a year ago. RTT News BioMarin Pharmaceuticals Announce Acquisition of Huxley - Oct 27, 2009 ...a product wholly developed and commercialized by BioMarin; Aldurazyme® (laronidase) for mucopolysaccharidosis I (MPS I), a product which BioMarin ... TransWorldNews (press release) BioMarin Pharmaceutical Inc. - Pharmaceuticals & Healthcare - Deals and ... - Nov 9, 2009 BioMarin's product portfolio includes three approved products namely Naglazyme, Aldurazyme, and Kuvan. The company is headquartered at California, ... PR-Inside.com (Pressemitteilung) Genzyme Q3 Profit Falls 87%; Cuts FY09 Earnings Outlook - Update - Oct 21, 2009 Sales for Hurler syndrome treatment drug Aldurazyme increased marginally to $40.3 million from $38.2 million a year ago. In the Biosurgery segment, ... Trading Markets (press release) |
|
Health Home | Conditions | Cancer | Medications | Surgery | Vaccines The Cancer News Network
COPYRIGHT 2009 CANCERNEWSNETWORK | Privacy |